Sign inJoin waitlistJoin the waitlist

Hassan Hatoum

Associate Professor · University of Oklahoma College of Medicine

Credentials: · · · ·

History

University of Oklahoma College of Medicine
Present

Hematology and Medical Oncology
2013–2016
Internal Medicine
Zucker School of Medicine at Hofstra/Northwell
2010–2013
Doctor of Medicine
1996–2000

Research

Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)
Blood · 2009 · 145 citations
Serotonin Pathway in Cancer
Review · International Journal of Molecular Sciences · 2021 · 126 citations
Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study
Journal of Clinical Oncology · 2020 · 116 citations

Zaher Otrock
11 papers · 10 as a resident
Sarbajit Mukherjee
6 papers
EO
Eileen O'Reilly
4 papers
AS
Achraf Shamseddine
3 papers
AZ
Alice Zervoudakis
3 papers
Carlos Chan
3 papers
Fouad Boulos
3 papers
KF
Karine Al Feghali
3 papers
RL
Robert Lentz
3 papers
Sagila George
3 papers
Zev Wainberg
3 papers
AT
Ahmad Tarhini
2 papers

Clinical trials

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2024–2027
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Site PI · Recruiting · Phase 2, Phase 3
NRG Oncology
2022–2030
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2022–2027
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2022–2027